Data were obtained from GLOBOCAN 2022 (185 countries), United Nations population and all-cause mortality data from WHO, and longitudinal data on breast cancer incidence between 2003 and 2017 from CI5 Plus database. (IMAGE)
Caption
Data were obtained from GLOBOCAN 2022 (185 countries), United Nations population and all-cause mortality data from WHO, and longitudinal data on breast cancer incidence between 2003 and 2017 from CI5 Plus database. The AMP method was used to calculate lifetime risk, which accounts for multiple primary cancers, competing risks from other causes of death, and life expectancy. Analyses estimated lifetime risk across different global regions, countries, age groups, socioeconomic conditions, and menopausal status. The findings showed that the lifetime risk of developing breast cancer was 5.51% and dying from breast cancer was 1.82%. Epidemiologic disparities of breast cancer were noted in different HDI regions and healthcare resource countries globally with pronounced heterogeneity. Countries should implement precise prevention and control measures based on their respective health resources and risk profiles to reduce the global burden of breast cancer. Figure created using Microsoft Office PowerPoint and Adobe Illustrator. (AAPC, average annual percentage change; AMP method, adjusted for multiple primaries method; CI5, cancer incidence in five continents; HDI, Human Development Index).
Credit
Cancer Biology & Medicine
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted.
License
CC BY-NC